Skip to content

Improving self-esteem in traumatized youth: a transdiagnostic ecological momentary intervention trial (SELFIE)

Improving self-esteem in traumatized youth: a transdiagnostic ecological momentary intervention trial (SELFIE) - SELFIE

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON52597
Enrollment
174
Registered
2018-08-01
Start date
2018-12-01
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

transdiagnostic study population, i.e., all youth exposed to childhood trauma) mental health problems

Interventions

Participants allocated to the experimental condition will receive the manualised SELFIE with a trained clinical psychologist within a 6-week period after randomization in addition to TAU. The interv

Sponsors

Universiteit Maastricht
Lead Sponsor

Eligibility

Age
12 Years to 64 Years

Inclusion criteria

Inclusion criteria: 1. Aged between 12 and 26 years 2. Score on questionnaires: * RSES

Exclusion criteria

Exclusion criteria: 1. Insufficient command of Dutch so that the self-esteem EMI cannot be followed and outcomes cannot be reasonably assessed in Dutch 2. Psychiatric symptoms due to an organic cause

Design outcomes

Primary

MeasureTime frame
Primary outcomes will be the level of self-esteem as measured with Ecological Momentary Assessment using the PsyMate® App, the Rosenberg Self-Esteem Scale, and semi-structured interviews.

Secondary

MeasureTime frame
Secondary outcomes will be implicit self-esteem, positive and negative schematic beliefs of self, resilience, self-compassion, emotional well-being, general psychopathology, functioning, and quality of life. Given that exposure to trauma and response to treatment may be reflected at the biological level in distinct epigenetic signatures, levels of DNA methylation in NR3C1 (i.e. glucocorticoid receptor 1 gene) and SLCA4 (i.e. the serotonin transporter gene) will be measured using targeted sequencing.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)